NF-κB inhibition was one of the main downstream effects of TREK-1 blockage, IL-4 administration, NLRC5 deficiency, and CTRP3 overexpression, and it was associated with reduced depression-like behaviors in UCMS mice [61,62,63,64]. Here, NFKB1 is linked to depressive symptom measurement.